Molecular Partners Ag (MOLN) Treasury Shares (2022 - 2026)
Molecular Partners Ag (MOLN) posted quarterly Treasury Shares of -$1446.8 for Q1 2026, down 32.6% year-over-year from -$2146.7 in Q1 2025, and down 2.43% quarter-over-quarter from -$1412.6 in Q4 2025.
Molecular Partners Ag (MOLN) Treasury Shares (2022 - 2026) Analysis & Trends
Molecular Partners Ag (MOLN) has reported Treasury Shares for 5 consecutive years, with -$1446.8 the latest figure, recorded in Q1 2026.
- In Q1 2026, Treasury Shares fell 32.6% year-over-year to -$1446.8; the TTM figure through Mar 2026 stood at -$1446.8 (down 32.6% YoY), while the FY2025 annual figure was -$1412.6, down 100.13% from the prior year.
- Treasury Shares eased to -$1446.8 in Q1 2026 per MOLN's latest filing, from -$1412.6 in the prior quarter.
- Across five years, Treasury Shares topped out at $1.1 million in Q4 2024 and bottomed at -$1.1 million in Q2 2023.
- Historically, Treasury Shares has averaged $70405.1 across 5 years, with a median of -$1123.9 in 2024.
- On a YoY basis, Treasury Shares climbed as much as 99.87% in 2025 and fell as far as 100.13% in 2025.
- Molecular Partners Ag's Treasury Shares stood at $1.0 million in 2022, then climbed by 8.61% to $1.1 million in 2023, then rose by 1.26% to $1.1 million in 2024, then plunged by 100.13% to -$1412.6 in 2025, then dropped by 2.43% to -$1446.8 in 2026.
- Business Quant data shows MOLN's Treasury Shares at -$1446.8 in Q1 2026, -$1412.6 in Q4 2025, and -$1411.4 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | Molecular Partners Ag | 163.99 Mn | 163.99 Mn | - | -1,446.85 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,446.85 |
| Mar 31, 2026 | -1,446.85 |
| Dec 31, 2025 | -1,412.57 |
| Dec 31, 2025 | -1,412.57 |
| Sep 30, 2025 | -1,411.37 |
| Sep 30, 2025 | -1,411.37 |
| Jun 30, 2025 | -1,361.29 |
| Jun 30, 2025 | -1,361.29 |
| Mar 31, 2025 | -1,091.12 |
| Mar 31, 2025 | -1,091.12 |
| Dec 31, 2024 | 1.12 Mn |
| Dec 31, 2024 | 1.12 Mn |
| Sep 30, 2024 | -1,132.28 |
| Sep 30, 2024 | -1,132.28 |
| Jun 30, 2024 | -1.08 Mn |
| Jun 30, 2024 | -1.08 Mn |
| Mar 31, 2024 | -1,123.91 |
| Mar 31, 2024 | -1,123.91 |
| Dec 31, 2023 | 1.11 Mn |
| Dec 31, 2023 | 1.11 Mn |